Hosted: June 23, 2023

Affecting as many as 500,000 Americans, bronchiectasis (BE) is an under-diagnosed chronic lung disease that causes permanent airway damage and retained secretions. Often misdiagnosed as asthma or COPD, BE requires a range of therapeutic interventions, including airway clearance therapy. In this on-demand webinar hosted by RT Magazine, a panel of respiratory and pulmonary experts discussed effective and successful strategies for treating bronchiectasis, including:

  • The clinical impact of bronchiectasis;
  • Treatment options, including pharmacological therapy and airway clearance therapy; and
  • A look at established hospital bronchiectasis programs for successful tips on creating a new program.


Joseph E. Khabbaza, MD
Pulmonologist, The Cleveland Clinic
Director, Non-CF Bronchiectasis Program, The Cleveland Clinic

Bill Pruitt, MBA, RRT, CPFT, FAARC
Registered Respiratory Therapist
Senior Instructor Emeritus and Former Director of Clinical Education
Dept of Cardiorespiratory Sciences, University of South Alabama

This webinar was generously sponsored by Tactile Medical.